PDL1 expression is associated with longer postoperative, survival in adrenocortical carcinoma

Adrenocortical carcinomas (ACCs) are heterogeneous cancers associated with a very poor prognosis. The improvement of prognostic tools and systemic therapy are urgently needed. Targeting the immune system using checkpoint inhibitors such as PD1/PDL1 inhibitors is an attractive novel therapeutic strat...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncoimmunology
Autori principali: Billon, Emilien, Finetti, Pascal, Bertucci, Alexandre, Niccoli, Patricia, Birnbaum, Daniel, Mamessier, Emilie, Bertucci, François
Natura: Artigo
Lingua:Inglês
Pubblicazione: Taylor & Francis 2019
Soggetti:
Original Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6791455/
https://ncbi.nlm.nih.gov/pubmed/31646101
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2019.1655362
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi